Clik here to view.
Second Sight将于2015年3月9日在ROTH第27届年会上呈报
加州SYLMAR (美国商业资讯) — Second Sight Medical Products, Inc. (NASDAQ:EYES) （”Second Sight”或”公司”）是为失明患者提供视觉功能的植入式视觉假体的开发者、制造商和营销商，该公司今天宣布，公司总裁兼首席执行官Robert Greenberg博士将在ROTH资本合伙人第27届年会上呈报，详情如下： 日期：...
View ArticleClik here to view.
Japanese Regulatory Agency Licenses Certara’s Phoenix and Simcyp Software to...
PRINCETON, N.J. Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that the Japanese Pharmaceuticals and Medical Devices...
View ArticleClik here to view.
14th Annual International Forum on Consciousness Topic Announced, Conscious...
MADISON, Wis. Join scientists, writers, religious leaders, futurists and other global experts in examining the mysteries of consciousness and how we may participate in shaping our collective future...
View ArticleClik here to view.
クインタイルズがElgar Peerschkeを助言サービス部門プレジデントに任命
米ノースカロライナ州リサーチ・トライアングル・パーク （ビジネスワイヤ） — クインタイルズは本日、Elgar Peerschkeを助言サービス部門プレジデントに任命したと発表しました。Peerschkeはこの職務で、クインタイルズの助言サービス部門を統率し、関連サービスの継続的な開発と実行に責任を持ちます。 クインタイルズの助言サービス部門プレジデントに新しく就任したElgar...
View ArticleClik here to view.
クインタイルズがIDGのCSOマガジンから3度目の技術セキュリティー賞を受賞
米ノースカロライナ州リサーチ・トライアングル・パーク （ビジネスワイヤ） — クインタイルズは本日、IDGのCSOマガジンによって2015 CSO50に選定されたことを発表しました。選定理由は、Windows XPのセキュリティー上の課題を管理するための当社のリスク軽減戦略が評価されたことです。...
View ArticleClik here to view.
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results...
CAMBRIDGE, Mass. & STOCKHOLM Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced positive top-line results of the Kids B-LONG Phase 3 clinical...
View ArticleClik here to view.
CHMP RECOMMENDS JINARC® (TOLVAPTAN) FOR APPROVAL IN EU: THE FIRST...
TOKYO Otsuka Pharmaceutical Co., Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended JINARC® (tolvaptan) for...
View ArticleClik here to view.
Arcadia Biosciences, Inc.就拟定的首次公开募股提交登记声明
加州戴维斯 (美国商业资讯)–Arcadia Biosciences, Inc.今天宣布，该公司已就其拟定的普通股首次公开募股向美国证券交易委员会(SEC)提交S-1登记声明。即将发售的股数和拟定公开募股的股价范围尚未确定。Arcadia打算通过纳斯达克全球市场发售其普通股，股票代码为“RKDA”。 瑞士信贷证券（美国）有限责任公司和摩根大通证券有限责任公司将担任联席牵头簿记管理人，Piper...
View ArticleClik here to view.
昆泰任命Elgar Peerschke为咨询服务总裁
北卡罗来纳州三角研究园 (美国商业资讯)–昆泰(Quintiles)今天宣布任命Elgar Peerschke为咨询服务(Advisory Services)总裁。在这一职位上，Peerschke将负责领导昆泰的咨询服务组织及其相关服务的持续开发和交付。 新任命的昆泰咨询服务总裁Elgar Peerschke（照片：美国商业资讯） 加入昆泰前，Elgar任职Bain &...
View ArticleClik here to view.
NDS Surgical Imaging Announces New 27” Radiance® Ultra, a Revolutionary...
SAN JOSE, Calif. NDS Surgical Imaging (NDSsi) today announced the release of its highly anticipated 27” Radiance® Ultra, a next-generation surgical visualization platform boasting the brightest LED...
View ArticleClik here to view.
昆泰第三次荣获IDG旗下《CSO》杂志评选的技术安全奖
北卡罗来纳三角研究园 (美国商业资讯)–昆泰(Quintiles)今日宣布，公司已获选进入IDG旗下《CSO》杂志2015 CSO50名单，以表彰昆泰用于管理Windows XP安全挑战的风险消减策略。 《CSO》杂志赞扬了昆泰团队创新的深度防御模式，该模式将基于Windows XP的关键业务应用的安全风险降到了最低水平，从而在交付安全和分段式平台的同时保护公司关键资产。...
View ArticleClik here to view.
Novacyt and Leica Biosystems Sign Major Distribution Deal for NOVAprep® in...
PARIS & CAMBRIDGE, England Novacyt (ALTERNEXT:ALNOV), an international specialist in cancer and infectious disease diagnostics, and Leica Biosystems, a leading supplier to the pathology market,...
View ArticleClik here to view.
Acucela to Hold 2015 Annual Meeting of Shareholders on June 8, 2015
SEATTLE Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of...
View ArticleClik here to view.
Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of...
TOKYO & KENILWORTH, N.J. Eisai Co., Ltd. and Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, through a subsidiary, announced today a clinical trial collaboration to evaluate the...
View ArticleClik here to view.
ViroMed Co., Ltd. dba VM BioPharma: A Phase II Study Done at Northwestern...
ATLANTA & SEOUL, South Korea Northwestern Memorial Hospital (Northwestern University‘s Feinberg School of Medicine) announced the results from a new phase II clinical study published in the...
View ArticleClik here to view.
R-Tech Ueno: The End of a Phase 3 Clinical Study and Preliminary Findings...
TOKYO R-Tech Ueno (JASDAQ: 4573) announced today the end of a Phase 3 clinical study with Unoprostone (development code UF-021) ophthalmic solution that are being developed in our company for the...
View ArticleClik here to view.
セジデム・リレーションシップ・マネジメントがライフサイエンス企業の営業チーム向けにマルチチャネル能力の拡大を発表
パリ （ビジネスワイヤ） — セジデム・リレーションシップ・マネジメントは本日、リモートインタラクションを行うためのKadrige iDetailingソリューションと、セジデムの顧客関係管理（CRM）ソリューションであるモバイル・インテリジェンス（Mobile...
View ArticleClik here to view.
Five Year Peak Sales Forecast of Newly Reimbursed Drugs in Japan Surges to $34bn
LONDON & BOSTON & TOKYO Despite depreciation of the Japanese Yen, the overall output of the Japanese drug industry measured by expected peak sales potential of newly National Health...
View ArticleClik here to view.
Delaware Court Finds That THERAVECTYS is Reasonably Likely to Succeed on the...
PARIS THERAVECTYS announced today a ruling by the Delaware Court of Chancery on the motion for preliminary injunction filed by THERAVECTYS against Immune Design Corp. (“IDC”) in a lawsuit filed in...
View ArticleClik here to view.
Open Monoclonal Technology Announces OmniAb™ Alliance with Celgene
PALO ALTO, Calif. Open Monoclonal Technology, Inc. (OMT) today announced a license that provides Celgene Corporation (Celgene) with unlimited access to OMT’s proprietary OmniRat®, OmniMouse® and...
View Article